The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes

International Journal of Obesity

Volumn 30, Issue 6, 2006, Pages 877-883

  Bonen, A ^a   Tandon, N N ^b   Glatz, J F C ^c   Luiken, J J F P ^c   Heigenhauser, G J F ^d  

^a UNIVERSITY OF GUELPH   (Canada)

^b OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Fatty acids; Glucose; Insulin; Transport

Indexed keywords

CD36 ANTIGEN; FATTY ACID; GLUCOSE; INSULIN; LEPTIN;

ABDOMINAL SURGERY; ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FATTY ACID TRANSPORT; FEMALE; GENERAL ANESTHESIA; HUMAN; INSULIN RESISTANCE; LEAN BODY WEIGHT; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS TISSUE; VISCERA;

ADULT; AGED; ANTHROPOMETRY; ANTIGENS, CD36; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN; INTRA-ABDOMINAL FAT; LEPTIN; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; SUBCUTANEOUS FAT;

EID: 33744454918     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803212     Document Type: Article

References (31)

1. Boden G. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc Assoc Am Physicians 1999; 111: 241-248.
2. Boden G, Chen X. Effects of fat on glucose uptake and utilization patients with non-insulin dependent diabetes mellitus. J Clin Invest 1995; 96: 1261-1268.
3. Kelley DA, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance. A reexamination. Diabetes 2000; 49: 677-683.
4. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97: 2859-2865.
5. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106: 171-176.
6. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phsophatidylinositol 3-kanise activity in muscle. J Biol Chem 2002; 277: 50230-50236.
7. Kim Y-B, Shulman GI, Kahn BB. Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C λ/ζ but not on glycogen synthase kinase-3. J Biol Chem 2002; 277: 32915-32922.
8. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JFC et al. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 2004; 18: 1144-1146.
9. Luiken JJFP, Arumugam Y, Dyck DJ, Bell RC, Pelsers ML, Turcotte LP et al. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 2001; 276: 40567-40573.
10. Luiken JJFP, Arumugam Y, Bell RC, Calles-Escandon J, Tandon NN, Glatz JFC et al. Changes in fatty acid transport and transporters are related to the severity of insulin deficiency. Am J Physiol Endocrinol Metab 2002; 282: 612-621.
11. Kim JK, Gimeno RE, Higashimori T, Kim H-J, Choi H, Punreddy S et al. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J Clin Invest 2004; 113: 756-763.
12. Bonen A, Luiken JJFP, Lui S, Dyck DJ, Kiens B, Kristiansen S et al. Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol Endocrinol Metab 1998; 275: E471-E478.
13. Steinberg GR, Dyck DJ, Calles-Escandon J, Tandon NN, Luiken JJFP, Glatz JF et al. Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle. J Biol Chem 2002; 277: 8854-8860.
14. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Frieda S et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999; 274: 19055-19062.
15. Coburn CT, Knapp Jr FF, Febbraio M, Beets AL, Silverstein RL, Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissue of CD36 knockout mice. J Biol Chem 2000; 275: 32523-32529.
16. Bonen A, Campbell SE, Benton CR, Chabowski A, Coort SL, Han XX et al. Regulation of fatty acid transport by fatty acid translocase/CD36. Proc Nutr Soc 2004; 63: 245-249.
17. Goudriaan JR, Dahlmans VE, Teusink B, Ouwens DM, Febbraio M, Maassen JA et al. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J Lipid Res 2003; 44: 2270-2277.
18. Koonen DPY, Benton CR, Arumugam Y, Tandon NN, Calles-Escandon J, Glatz JFC et al. Different mechanism can alter fatty acid transport when muscle contractile activity is chronically altered. Am J Physiol Endocrinol Metab 2004; 286: 1042-1049.
19. Gertow K, Bellanda M, Eriksson P, Boquist S, Hamsten A, Sunnerhagen M et al. Genetic and structural evaluation of fatty acid transport protein-4 in relation to markers of the insulin resistance syndrome. J Clin Endocrinol Metab 2004; 89: 392-399.
20. Fisher RM, Hoffstedt J, Hotamisligil GS, Thorne A, Ryden M. Effects of obesity and weight loss on the expression of proteins involved in fatty acid metabolism in human adipose tissue. Int J Obes Relat Metab Disord 2002; 26: 1379-1385.
21. Asakawa H, Tokunaga K, Kawakami F. Relationship of abdominal fat with metabolic disorders in diabetes mellitus patients. Diabetes Res Clin Pract 2002; 55: 139-149.
22. Kelley DE, Thaete FE, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000; 278: E941-E948.
23. Matsuno K, Diaz-Ricard M, Montgomery RR, Aster T, Jamieson GA, Tandon NN. Inhibition of platelet adhesion to collagen by monoclonal anti CD36 antibodies. Br J Haematol 1996; 92: 960-967.
24. Bergmeyer HU. Methods of Enzymatic Analysis. Academic Press: New York, 1983.
25. Gertow K, Pietilainen KH, Yki-Jarvinen H, Kaprio J, Rissanen A, Eriksson P et al. Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance. Diabetologia 2004; 47: 1118-1125.
26. Chabowski A, Coort SL, Calles-Escandon J, Tandon NN, Glatz JF, Luiken JJ et al. Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm. Am J Physiol Endocrinol Metab 2004; 287: E781-E789.
27. Rome S, Clement K, Rabasa-Lhoret R, Loizon E, Poitou C, Barsh GS et al. Microarray profiling of human skeletal muscle reveals that insulin regulates ∼800 genes during a hyperinsulinemic clamp. J Biol Chem 2003; 278: 18063-18068.
28. Coort SL, Coumans WA, Bonen A, van der Vusse GJ, Glatz JF, Luiken JJ. Divergent effects of rosiglitazone on protein-mediated fatty acid uptake in adipose and in muscle tissues of Zucker rats. J Lipid Res 2005; 46: 1295-1302.
29. Chambrier C, Aouifi A, Bon C, Saudin F, Paturel B, Bouletreau P. Effects of intraoperative glucose administration on circulating metabolites and nitrogen balance during prolonged surgery. J Clin Anesthiol 1999; 11: 646-651.
30. Geisser W, Schreiber M, Hofbauer H, Lattermann R, Fussel S, Wachter U et al. Sevoflurane versus isoflurane - anaesthesia for lower abdominal surgery. Effects on perioperative glucose metabolism. Acta Anaesthesiol Scand 2003; 47: 174-179.
31. Lattermann R, Schricker T, Georgieff M, Schreiber M. Low dose clonidine premedication accentuates the hyperglycemic response to surgery. Can J Anaesthiol 2001; 48: 755-759.